Rationale and Design of the COPERNIC Trial: A Study of On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer Patients.

Auteurs

Assaf I, Bregni G, Anthoine G, Aparicio T, Artru P, Abdelghani MB, Buyse M, Chibaudel B, Coart E, Diaz M, Evrard C, Geboes K, Ghiringhelli F, Puleo F, Raimbourg J, Vandamme T, Van den Eynde M, Hendlisz A, Sclafani F

  • Date de publication

    September 2024
  • Type

    Article
  • Tijdschrift

    Clin Colorectal Cancer
  • Naam van de onderzoeker

    BREGNI GIACOMO
  • Hôpital

    Institut Jules Bordet
  • Dienst

    Médecine Oncologique
  • PMID

    39341700
  • DOI

    10.1016/j.clcc.2024.08.004